Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Seyyed Ali Ahmadi Abhari"'
Autor:
Hoorie Mohaghghegh, Esmaeil Shahsavand Ananloo, Mahmoudreza Hadjighasem, Morteza Karimipour, Shiva Hashemizadeh, Seyyed Ali Ahmadi Abhari
Publikováno v:
Journal of Molecular Neuroscience. 72:1670-1681
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c190e9563ca3be8bc2a1b69aa871428e
https://doi.org/10.1007/s12031-021-01879-7
https://doi.org/10.1007/s12031-021-01879-7
Autor:
Hoorie, Mohaghghegh, Esmaeil Shahsavand, Ananloo, Mahmoudreza, Hadjighasem, Morteza, Karimipour, Shiva, Hashemizadeh, Seyyed Ali Ahmadi, Abhari
Publikováno v:
Journal of molecular neuroscience : MN. 72(8)
Schizophrenia (SCZ) is a debilitating, destructive, and chronic mental disorder and affects approximately one percent of the human population. Diagnosis in psychiatry is based on the patient's descriptions of his/her symptoms, interviewer's observati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::74a5de158cd78ad2fe8e7647d350ffac
https://pubmed.ncbi.nlm.nih.gov/35624355
https://pubmed.ncbi.nlm.nih.gov/35624355
Autor:
Seyyed-Ali Ahmadi-Abhari, Shahin Akhondzadeh, Mina Tabrizi, Farahnaz Khalighi-Sigaroudi, Farzin Rezaei, Mohammad Arbabi, Mohaddeseh Bagheri
Publikováno v:
Psychopharmacology. 220(3)
In recent years, evidence suggests that modafinil may be useful for certain symptom domains of schizophrenia, especially for the negative and cognitive symptoms. However, the results are not consistent. This study was designed to investigate the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f32fe51b1cdcb92a4a159421f3f393
https://pubmed.ncbi.nlm.nih.gov/21947320
https://pubmed.ncbi.nlm.nih.gov/21947320